We will get back to you as soon as possibleReturn to the website
Import your raw data from the lab directly into our platform. In a very short time, OncoKDM will get you back a useful and comprehensive report that you can review, validate and then transfer to the oncologist.
OncoKDM is the platform that brings together a world of information and not only makes it more accessible, but also has a real added value for the clinicians, oncologists and molecular biologists.
Imagine a solution that integrates genomics, molecular pathology, IHC test results, and clinical data. Organizes them. Characterizes them. And personalizes them for you, at the level of the analysis pipeline and in your customized report.
Connect with one or a list of collaborators and share and discuss the report remotely and securely to make the right decision
Customize the bioinformatics pipeline, personalize the report according to your needs and specifications
Standardize your data to simplify further meta-analyses
Clinical annotation of not only the variants from NGS but also any results from any additional test
Get a report on the quality of your raw data
Edit and validate the report prior to submitting the final version to the oncologist
Classification of variants in NGS section of the customisable OncoKDM.
Biological and therapeutical interpretation of the NGS variants in OncoKDM.
Interpretation and integration of protein expression and MSI results in OncoKDM.
Baselining, analysis and interpretation of Copy Number Variations in OncoKDM
Detailed sequencing panel coverage in OncoKDM report displayed by gene and by exon
Interpretation based on the combination of all available data from one tumor sample
Classification of the treatment options for each tumor derived from its biological data
Automated data analysis and interpretation but fully editable and customisable
Given the expertise of OncoDNA delivering solutions in precision medicine, we initiate this collaboration with enthusiasm to produce a specific SOLTI OncoKDM solution which will integrates the current and future molecular data types that might reveal unappreciated vulnerabilities in the tumor of AGATA patients that will allow us to tailor much better their treatment options
I'm an early user of OncoSHARE, the first reporting system developed by OncoDNA. I like the interpretation system which combines DNA and RNA sequencing, pathology, immunohistochemistries,… Now with this new tool, OncoKDM, I'm very glad that our laboratory can use it to perform interpretation of our cancer data.